These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 25023322)

  • 41. High-throughput screening techniques for rapid PEG-based precipitation of IgG4 mAb from clarified cell culture supernatant.
    Knevelman C; Davies J; Allen L; Titchener-Hooker NJ
    Biotechnol Prog; 2010; 26(3):697-705. PubMed ID: 20014099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small-angle x-ray scattering screening complements conventional biophysical analysis: comparative structural and biophysical analysis of monoclonal antibodies IgG1, IgG2, and IgG4.
    Tian X; Langkilde AE; Thorolfsson M; Rasmussen HB; Vestergaard B
    J Pharm Sci; 2014 Jun; 103(6):1701-10. PubMed ID: 24700358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the chromatographic properties of IgG1 and IgG2 antibody subclasses.
    Ghose S; Ladwig J; Allen M
    Biotechnol Appl Biochem; 2010 Dec; 57(3):111-6. PubMed ID: 20874708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction.
    Gentiluomo L; Roessner D; Streicher W; Mahapatra S; Harris P; Frieß W
    J Pharm Sci; 2020 Jan; 109(1):443-451. PubMed ID: 31563513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.
    Kayser V; Chennamsetty N; Voynov V; Forrer K; Helk B; Trout BL
    Biotechnol J; 2011 Jan; 6(1):38-44. PubMed ID: 20949542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-throughput screening of formulations to optimize the thermal stability of a therapeutic monoclonal antibody.
    Niedziela-Majka A; Kan E; Weissburg P; Mehra U; Sellers S; Sakowicz R
    J Biomol Screen; 2015 Apr; 20(4):552-9. PubMed ID: 25385011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody.
    Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive Nature of High-Throughput Assays in ADC Formulation Screening.
    Mills BJ; Godamudunage MP; Ren S; Laha M
    J Pharm Sci; 2023 Jul; 112(7):1821-1831. PubMed ID: 37037342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrasonic rheology of a monoclonal antibody (IgG2) solution: implications for physical stability of proteins in high concentration formulations.
    Saluja A; Badkar AV; Zeng DL; Kalonia DS
    J Pharm Sci; 2007 Dec; 96(12):3181-95. PubMed ID: 17588261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.
    Thakkar SV; Sahni N; Joshi SB; Kerwin BA; He F; Volkin DB; Middaugh CR
    Protein Sci; 2013 Oct; 22(10):1295-305. PubMed ID: 23893936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Crystal Zenith Microtiter Plates for High-Throughput Formulation Screening.
    Floyd JA; Shaver JM; Gillespie AJ; Park U; Rogers RS; Nightlinger NS; Ogata Y; James JJ; Kerwin BA
    J Pharm Sci; 2020 Jan; 109(1):532-542. PubMed ID: 31669607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetic analysis of the multistep aggregation mechanism of monoclonal antibodies.
    Nicoud L; Arosio P; Sozo M; Yates A; Norrant E; Morbidelli M
    J Phys Chem B; 2014 Sep; 118(36):10595-606. PubMed ID: 25119992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
    Wuchner K; Büchler J; Spycher R; Dalmonte P; Volkin DB
    J Pharm Sci; 2010 Aug; 99(8):3343-61. PubMed ID: 20229596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.
    Thirumangalathu R; Krishnan S; Ricci MS; Brems DN; Randolph TW; Carpenter JF
    J Pharm Sci; 2009 Sep; 98(9):3167-81. PubMed ID: 19360857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gauging colloidal and thermal stability in human IgG1-sugar solutions through diffusivity measurements.
    Rubin J; Sharma A; Linden L; Bommarius AS; Behrens SH
    J Phys Chem B; 2014 Mar; 118(11):2803-9. PubMed ID: 24555903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advancements in high throughput biophysical technologies: applications for characterization and screening during early formulation development of monoclonal antibodies.
    Samra HS; He F
    Mol Pharm; 2012 Apr; 9(4):696-707. PubMed ID: 22263524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Use of a GroEL-BLI Biosensor to Rapidly Assess Preaggregate Populations for Antibody Solutions Exhibiting Different Stability Profiles.
    Pace SE; Joshi SB; Esfandiary R; Stadelman R; Bishop SM; Middaugh CR; Fisher MT; Volkin DB
    J Pharm Sci; 2018 Feb; 107(2):559-570. PubMed ID: 29037466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agitation-induced aggregation and subvisible particulate formation in model proteins.
    Jayaraman M; Buck PM; Ignatius AA; King KR; Wang W
    Eur J Pharm Biopharm; 2014 Jul; 87(2):299-309. PubMed ID: 24462794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.